Document Detail


Molecular basis for hyperkalemic periodic paralysis.
MedLine Citation:
PMID:  11980067     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
At least one form of periodic paralysis is a direct consequence of a mutation in a skeletal muscle, voltage-sensitive sodium channel--it was observed that many individual with this disease developed low serum potassium levels during paralytic episodes. Some families had hyperkalemic paralysis with serum potassium levels of 6 or 7 mEg/L during paralytic crises. In both hypokalemic and hyperkalemic paralysis one of the precipitants is a period of rest after exertion. In hypokalemic periodic paralysis carbohydrates may initiate weakness. In both hyper- and hypokalemic forms, the disorder is inherited as an autosomal dominant trait. During hypokalemic and hyperkalemic paralysis, one might respectively anticipate muscle hyperpolarization or depolarization. Has been observed a potassium-related abnormality of sodium conductance in the pathogenesis at least of the hyperkalemic form of periodic paralysis. The fact that TTX reverses the physiological defect suggested the hypothesis that the primary problem might be a mutation in a TTX-sensitive sodium channel. The protein consists of some 2000 amino acids with characteristic intracytoplasmic and extracellular domains as well a four remarkably conserved membrane spanning domains, each composed of six transmembrane of a polymorphism of the human sodium channel with hyperkalemic paralysis. When multipoint analysis was used to test for coinheritance of the disease with both Na-2 and growth hormone polymorphisms, a lod score of 7 was obtained. That is, the ratio of the probability of linkage to non-linkage is 10 million to one. When extracellular potassium is increased to 10 mM, the affected myotubes demonstrate strikingly abnormal channel behavior characterized by prolonged open times or repetitive opens throughout the voltage step. Potassium implicate as a primary factor triggering an abnormal sodium channel gating mode and, as a result, aberrant sodium current behavior. It was estimated that, for the normal channel, the probability of entering a non-inactivating mode was very low and independent of potassium. On the other hand, for the abnormal channel the probability of entering an inactive mode rises up to 5-fold with hyperkalemic. Four mutations have recently been detected in individuals with cold-sensitive paramyotenia congenital. Two of the cause amino acid substitutions within the III-IV intracytoplasmic loop. It is striking that one substitutes a valine for a glycine. An analysis of the molecular biology of each mutation should illuminate not only the disease phenotype but also biophysical properties of specific sub-regions of this muscle sodium channel.
Authors:
R H Brown
Related Documents :
11714887 - Kinetics of modulation of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium chan...
9522147 - Molecular actions of droperidol on human cns ion channels.
6633657 - Optical recording of action potentials from vertebrate nerve terminals using potentiome...
19115387 - Sodium channel activity modulates multiple functions in microglia.
16225177 - The pentapeptide qynad does not inhibit neuronal network activity.
7757407 - Spontaneous activity: functions of calcium transients in neuronal differentiation.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of neurology     Volume:  25-26     ISSN:  0020-7446     ISO Abbreviation:  Int. J. Neurol.     Publication Date:    1991-1992
Date Detail:
Created Date:  2002-04-30     Completed Date:  2002-05-16     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0374722     Medline TA:  Int J Neurol     Country:  Uruguay    
Other Details:
Languages:  eng     Pagination:  89-96     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Humans
Hyperkalemia / complications,  drug therapy,  genetics*
Paralysis / drug therapy,  etiology,  genetics*
Potassium / physiology
Tetrodotoxin / therapeutic use
Chemical
Reg. No./Substance:
4368-28-9/Tetrodotoxin; 7440-09-7/Potassium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mapping of the tuberous sclerosis genes.
Next Document:  Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlyi...